Perm Medical JournalPerm Medical JournalПермский медицинский журнал (сетевое издание "Perm medical journal")0136-14492687-1408Eco-Vector679310.17816/pmj34294-102ArticlesСтатьиReview ArticleCARDIOVASCULAR AND INFLAMMATORY BOWEL DISEASES: COMORBIDITY OR POLYMORBIDITY?ЗАБОЛЕВАНИЯ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ И ВОСПАЛИТЕЛЬНЫЕ ЗАБОЛЕВАНИЯ КИШЕЧНИКА: КОМОРБИДНОСТЬ ИЛИ ПОЛИМОРБИДНОСТЬ?KhlynovaO VХлыноваОльга Витальевна

д.м.н., член-корр. РАН, профессор кафедры госпитальной терапии,

olgakhlynova@mail.ruTuevA VТуевАлександр Васильевич

д.м.н., профессор, зав. каф. госпитальной терапии

VasiletsL MВасилецЛюбовь Михайловна

д.м.н., профессор кафедры госпитальной терапии

KuznetsovaE SКузнецоваЕкатерина Сергеевна

студентка 6 курса лечебного факультета

Пермский государственный медицинский университет им. академика Е.А. Вагнера15042017342VOL 34, NO2 (2017)ТОМ 34, №2 (2017)9410211072017Copyright ©; 2017, Khlynova O.V., Tuev A.V., Vasilets L.M., Kuznetsova E.S.Copyright ©; 2017, Хлынова О.В., Туев А.В., Василец Л.М., Кузнецова Е.С.2017Khlynova O.V., Tuev A.V., Vasilets L.M., Kuznetsova E.S.Хлынова О.В., Туев А.В., Василец Л.М., Кузнецова Е.С.http://creativecommons.org/licenses/by-sa/4.0https://permmedjournal.ru/PMJ/article/view/6793

The review of literature, devoted to the problem of associated course of cardiovascular diseases among patients with inflammatory bowel diseases (IBD) (Crohn’s disease and ulcerous colitis) is presented in the paper. The data on the prevalence, common etiological and pathogenetic factors, peculiarities of clinical picture in IBD patients, when associated with a number of cardiovascular diseases, were analyzed. The results of work aimed at characterization of peculiar features of patients’ genetic, immunological and hemostesiological profile with syntropia of these diseases are indicated.

Представлен обзор литературы, посвященный описанию вопроса о сочетанном течении заболеваний сердечно-сосудистой системы среди лиц с воспалительными заболеваниями кишечника (ВЗК) (болезнь Крона и язвенный колит). Проанализированы данные о распространенности, общности этиологических и патогенетических факторов, особенностях клинической картины у пациентов с ВЗК при их ассоциированном течении с рядом заболеваний сердечно-сосудистой системы. Приведены результаты работ по характеристике особенностей генетического, иммунологического и гемостезиологического профиля пациентов при синтропии заболеваний.

Cardiovascular pathologyinflammatory bowel diseasesCrohn’s diseaseulcerous colitisПатология сердечно-сосудистой системывоспалительные заболевания кишечникаболезнь Кронаязвенный колитAlkan E., Serkan M., Yıldırım B. Atherosclerosis in inflammatory bowel disease. Turk J Gastroenterol 2014; 25 (1): 20-25.Bernstein С., Blanchard J., Houston D., Wanda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease. A population-based cohort study. J Thromb Haemost 2001; 85: 430-434.Bodegraven А., Schoorl M., Baak J., Linskens R. Hemostatic imbalance in active quiescent ulcerative colitis. J Gastroenterol 2001; 96: 487-493.Danese S., Papa A. PAI-1 and TAFI in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2008; 20: 826-828.Esmon C. Inflammation and thrombosis. J Thromb Haemost 2003; 1: 1343-1348.Evans P.E., Pardi D.S. Extra-intestinal manifestations of inflammatory bowel disease: Focus on the musculoskeletal, dermatologic, and ocular manifestations. Med Gen Med 2007; 9 (1): 55.Glas J., Seiderer J., Wagner J. Analysis of IL12B gene variants in inflammatory bowel disease. PLOS ONE. 2012; 7 (3): Article ID e34349.Grainge М., West J., Card T. Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. J Lancet 2010; 375: 657-663.Grip О., Svensson P., Lindgren S. Lindgren inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35: 619-623.Haslam N., Standen G., Probert C. An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 1289-1291.Hitomi S., Atsushi K., Shigeaki N. Extra intestinal complications of inflammatory bowel disease. J Nat Defense Med College 2002; 27 (1): 36-42.Kahn М., Peltier A., Meyer O., Piette J. Aorto-arterite non specifique (maladie de Takayasu). Les maladies systemiques. Paris: Flammarion Medecine Sciences 1991; 713-726.Kloudova М., Chovanec V., Vodnansky P., Elias P. Takayasu arteritis in Crohn’s disease. J Folia Gastroenterol Hepatol 2005; 3 (3): 92-98.Kusunoki R., Ishihara S., Sato M. Rare case of Takayasu's arteritis associated with Crohn’s disease. Internal Medicine 2011; 50 (15): 1581-1585.Liebman Н., Kashani N., Sutherland D., McGehee W. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. J Gastroenterology 1998; 11: 830-834.Maksimowicz-McKinnon K., Hoffman G. Crohn’s disease plus Takayasu’s arteritis: more than coincidence. An de Med Interne 2003; 154 (2): 75-76.Michail S., Bultron G., Depaolo R. Genetic variants associated with Crohn’s disease. Application of Clinical Genetics 2013; 6: 25-32.Mobini M., Hojati S. Case report: takayasu arteritis associated with ulcerative colitis. J Govaresh 2012; 17 (1): 60-63.Nasu T. Takayasu's trunco-arteritis. Pulseless disease or aortitis syndrome. J Pathol 1982; 32: 117-131.Oldenburg B., Fijnheer R., Griend R. Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications. Am J Gastroenterol 2000; 95: 2825-2830.Rellecke P., Strauer B. Chronic inflammatory bowel disease and cardiovascular complications. Med Klin 2006; 101 (1): 56-60.Rogler G., Scholmerich J. Extra-intestinal manifestations of inflammatory bowel disease. Med Clin 2004; 99 (3): 123-130.Romagnuolo J., Fedorak R., Dias V. Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study. Am J Gastroenterol 2001; 96: 2143-2149.Rosello-Diez E., Munoz-Guijosa C., Ginel A., Padro J. Coronary artery aneurysms and inflammatory bowel disease: a rare association case report. J The Open Cardiovascular and Thoracic Surgery 2012; 5: 35-37.Saibeni S., Saladino V., Chantarangkul V. Increased thrombin generation in inflammatory bowel diseases. J Thromb Res 2010; 125: 278-282.Silverstein A., Present D. Cerebrovascular occlusions in relatively young patients with regional enteritis. The Journal of the American Medical Association 1971; 215 (6): 976-977.Singh N., Saurabh S., Tan J. Takayasu’s arteritis and crohn’s disease in a young hispanic female. J Case Reports in Rheumatology 2014; 3: 140-145.Soloway M., Moir T., Linton D. Takayasu’s arteritis. Report of a case with unusual findings. The American Journal of Cardiology 1970; 25 (2): 258-263.Talbot R., Heppel J., Dozois R., Beart R. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-145.Terao C., Yoshifuji H., Kimura A. Two susceptibility Loci to Takayasu’s arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. The American Journal of Human Genetics 2013; 93 (2): 289-297.Tezel A., Demir M. Thrombosis in Inflammatory bowel disease. Turk J Hematol 2012; 29: 111-119.Thabassum H., Kumar L., Puste S. An unusual association of takayasu’s arteritis with inflammatory bowel disease - a rare case report. International Journal of Scientific and Research Publications 2015; 5 (4): 1-3.Thomson N., Wakefield A., Pounder R. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. J Gastroenterology 1995; 108: 1011-1015.Wang K., Zhang H., Kugathasan S. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn’s disease. American Journal of Human Genetics 2009; 84 (3): 399-405.Yorulmaz E., Pehlivanoglu V., Tuncer I., Kiziltas S. Takayasu's arteritis in a case diagnosed as Crohn's disease. Turk J Gastroenterol 2007; 18 (4): 250-253.